Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure

NCT02934971 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT02934971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02934971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure
Lead sponsor
RWTH Aachen University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
January 31, 2019
Enrollment
470 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

toxicity due to chemotherapy